Msb

Biotech Company who has done some successful trials on Ventilator patients with COVID-19. Shares doubled in US on Friday, expecting huge opening on ASX this morning, will be fun to watch.

Disc: HOLD

Will MSB end up the most expensive stock on the Aust market. Looks like it could be DYOR.

Clinically it may help but is it any better than other treatments?
https://www.theguardian.com/world/co...o-magic-bullet
https://www.sciencedaily.com/release...0324202056.htm

Its maniacal on the H/C thread. Serial cap raises ,re$ 600 mill in last 6 or 7 years and still losing heaps$. Huge leap of faith . Avoid imo until they actually start making money, if they ever do. Promises ,promises.

Dropped 31% today on an iminent decision. Is MSB the real deal, alot of runs to the exit for this traders plaything?Reality bites?

Update on Scheduled FDA Advisory Committee Meeting

Down more today. Inside info, or just nerves? From a brief glance, the data wasn't as good as I would of liked and if we compare it with ivermectin taken with two other already FDA approved treatments, then the cost of stemcells makes it look very unattractive.....but on the flipside, I invested ... Despite knowibg this,

what a difference 2 days can make - FDA approval voted 9-1, share back to trading.

On a string back to where it was but no further!? Boing.

Download Document 117.69KB

Quote:

---

Originally Posted by Joshuatree

On a string back to where it was but no further!? Boing.

Download Document 117.69KB

---

Yes, thats the disappointing aspect, thought it would be up around mid to late 5's if not 6. More to come.

Quote:

---

Originally Posted by Joshuatree

Its maniacal on the H/C thread. Serial cap raises ,re$ 600 mill in last 6 or 7 years and still losing heaps$. Huge leap of faith . Avoid imo until they actually start making money, if they ever do. Promises ,promises.

---

Try not to let the truth stand in the way of a good slap down on share-trader. MSB have been making money, not in profit yet, but in my opinion Alogenic stem cells are the future of medicine, and I will stick my neck out and say that "I believe MSB is the 'Tesla' of medicine. My only caveat is that 'big-pharma' is so powerful that they alone could kill this, so they can keep on pedaling their pills.


MSB Financial Highlights for the First Quarter FY2020


46% growth in revenue due to:
43% increase in milestone revenues from strategic partnerships (US$15.0 million compared with US$10.5 million for the first quarter of FY2019).
85% growth in revenues from sales of TEMCELL®1 HS. Inj. by Mesoblast’s licensee for steroid refractory acute graft versus host disease (aGVHD) in Japan compared to the first quarter of FY2019.
MCS have been saving lives of children under 12yo in Japan, and the recent ODAC vote was to recommend to the FDA that they approve MSC,s for use for this same condition for children in the USA,
It just "turn's out" that the same 'over reaction' of the infants immune system is what is causing so many covid19 deaths.( ARDS ) and any day now there will be the first read out of the 300 patient, double blind trial of MCS on covid patients on ventillators in the US. That will be the day when this stops being a 'Traders plaything'
PENN (happy holder- not advice!)

Congrats , hope you're in the money. S/P jumps from re $3 to $5 on FDA approval.


Download Document 117.69KB

[QUOTE=Joshuatree;837776]Congrats , hope you're in the money. S/P jumps from re $3 to $5 on FDA approval.
So FDA due to decide in 72hrs (US time) now we get to the pointy end, MSB up 12% today on the ASX (52week high) will trade on NASDAC tonight then we wait for the FDA Dis-approval or otherwise. I am expecting to see MSB on the TV news by Saturday, for being the first company on the planet to be approved by the FDA to provide an approved Mesenchymal stem cell therapy in the US and then there could be the "off Label" use for covid. (DYOR) Not advice, just my opinion. Penn.

https://www.youtube.com/watch?v=stLIHSo6-50
Is Mesoblast Going To Fly After FDA Approval?!| (ASX: MSB) | ASX Growth Stocks

Today we analyse our stock of the day - Mesoblast (ASX: MSB).
Mesoblast is an ASX Healthcare stock that utilises cell-based technology to develop innovative treatments to treat serious and life-threatening diseases.
Mesoblast has a significant product pipeline with numerous candidates in the process of Phase-3 trials on the path to FDA approval - today we discuss if their lead candidate Ryoncil (Remestecel-L) is approved by the FDA what will happen to Mesoblast and the MSB share-price.
Mesoblast is one of the most exciting healthcare and bio-tech companies on the ASX 200 and is one of the great ASX healthcare stocks to watch!

Trading Halt opens new window

Good luck holders

Quote:

---

Originally Posted by Joshuatree

Trading Halt opens new window

Good luck holders

---

Sadly the FDA released a Complete Response Letter and as I understand it they are asking for more data on how stem-cells work. And another trial, It's a disappointing set-back but is all part of the journey, and I will continue to hold, one day this will be front page news, but a while to wait still.

34% down ehhh .FDA wants more proof, another trial. S/P down 34% .Im still an occasional watcher on this one.

Quote:

---

Originally Posted by Joshuatree

34% down ehhh .FDA wants more proof, another trial. S/P down 34% .Im still an occasional watcher on this one.

---

No surprises here...lol.

"You know I'm no fan of Regal or the way the operate. They employ Craig Collie as an analyst and to give them advice. What they do with that advice is a different thing. I do happen to agree with him about MSB. I don't doubt they've been shorting it to the hilt based on his advice, and today the scoundrels made a significant amount of money. I also think they will stick around for the next trial result too because they expect it to be unfavourable. And they will probably be critical of MSB to their clients and perhaps in the media too. Their job now is to drive down the share price as far as they can."
From Whytee on H/C

53 competition entries - still time for the 2021 competition - go msb

Quote:

---

Originally Posted by percy

No surprises here...lol.

---

And another letdown for the sad do good dreamers.Kinda reminds me of NTL,so many promises and cap raises over many years and yet suckers keep believing and management keep getting fatter .